Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

dragon

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

Scopus Index (2025)

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi (ISSN:2219-4614 )(E-ISSN:2782-3687) is a monthly peer-reviewed scopus-indexed journal from 2001 to present. The publisher of this journal is ABV-press Publishing house. Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi committed to gathering and disseminating excellent research achievements. The journal welcomes all types of General Medicine journal includes Oncology , Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Orthopedics and Sports Medicine etc.

Aim And Scopes

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

General Medicine
Oncology
Pathology
Forensic Medicine
Radiology
Nuclear Medicine and Imaging
Orthopedics
Sports Medicine
Latest Journal Here
Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
SKMTOK-25-02-2025-3125 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Hibernoma: a case report and discussion of a rare tumor

Hibernomas account for less than 2 % of all benign lipomatous tumors and 1 % of all lipomatous tumors. They are usually found in 20–40-year old adults (the average age of patients is 38 years). The clinical manifestations are painless soft tissue mass that are mostly slow growing; rapid growth is only found in a small number of patients. We present a case of successful surgical treatment of a pathologically confirmed rare lipomatous tumor of large size, which was located in the soft tissues of the thigh. A 46-year-old woman was admitted to the hospital due to a tumor 20 × 10 &ti

Read More
SKMTOK-25-02-2025-3124 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Reconstruction of the left diaphragmic cupola using titanium nickelide metallic knitted mesh after combination resection due to leiomyosarcoma

Leiomyosarcoma of the diaphragm is an extremely rare disease. No more than 20 cases have been described so far. All patients needed reconstruction of the dome of the diaphragm, including with the use of implants. The article presents a clinical case of treatment of a 40-year-old woman with giant leiomyosarcoma of the left diaphragmic cupola. The ex- tirpation of the tumor as a single block with the diaphragm and the pericardial wall was performed, followed by the restoration of the abdominal obstruction with nickel-titanium metal knitwear.

Read More
SKMTOK-25-02-2025-3123 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Overall and relapse-free survival of dogs with appendicular osteosarcoma after limb-sparing bio-implantation treatment

Canine osteosarcoma is a most common bone tumor in dogs, usually involving long tubular bones lesion. Limb-sparing treatment method allows to save extremity functionality and sufficiently improve quality of life in comparison with amputation. To analyze the survival rates and local results after limb-sparing treatment of canine osteosarcoma using bio-implantation – de-immunized allogenic bone populated with recipient stromal mesenchymal cell preparation. Group of 25 dogs underwent a combined treatment including cisplatinum chemotherapy (60–70 mg/m2 intravenously infusion at 14&n

Read More
SKMTOK-25-02-2025-3122 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Perioperative hemorheological status of oncological patients with primary knee replacement

Periprosthetic joint infection (PJI) poses a challenging complication for many patients undergoing arthroplasty, and the literature identifies numerous risk factors. A comprehensive understanding of the primary risk and protective factors for PJI is valuable for surgeons. This article aims to compile and summarize the key risk factors for PJI documented in the literature. Some risk factors are related to the nutritional status of patients, with obesity, weight loss, hypovitaminosis, and malnutrition being frequently reported. Pathologies affecting patients also contribute to PJI risk, inclu

Read More
SKMTOK-25-02-2025-3121 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Atrial fibrillation and malignant neoplasms: state of the problem

Patients with malignant neoplasms have an increased risk of atrial fibrillation. Prevalence of this pathology among oncological patients is 20–30 %, and it significantly varies depending on tumor type, chemotherapy treatment and initial comorbid status. Atrial fibrillation and malignant neoplasms have similar risk factors. Researchers have identified several possible causes characteristic of these diseases, primarily, systemic inflammation. Some chemotherapies cause abnormalities in ionic channels of atrial cardiomyocytes which leads to changes in the action potential and refractory p

Read More